Benue State Commissioner for Information, Matthew Abo, and his counterpart from Plateau State, Joyce Ramnap, speak to GRACE ...

The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia ...

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...

Discover phases of acute ischemic stroke care, from rapid recognition to long-term recovery strategies that neurologists use ...

Detailed price information for Roche Holdings Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.

The Company announced a 10-year agreement with FUJIFILM Diosynth Biotechnologies (Fujifilm) to manufacture and supply Regeneron's commercial bulk drug product at Fujifilm's North Carolina campus. The ...

The MG-ADL scale ranges from 0 to 24 ... treated with nipocalimab were respiratory tract infections, peripheral edema, and muscle spasms. Prescribing information warns against administering ...

Methyl eugenol (ME) possesses significant antioxidant, anticancer and neuroprotective properties, potentially beneficial ...

Travere Therapeutics, Inc., and CSL Vifor are pleased to announce that the European Commission has approved the conversion of the conditional marketing approval (CMA) into a standard marketing ...

Eylea is used to treat diseases such as neovascular, or "wet," age-related macular degeneration, macular edema, and diabetic ... double the Company's large-scale manufacturing capacity in the ...